Well, I Guess We All Knew

How Google Search Rankings Are Silencing Alternative Health Websites

Analysis by Dr. Joseph Mercola
google silencing alternative health websites

STORY AT-A-GLANCE

  • Google slashed traffic to Mercola.com by 99.9%, replacing years of trusted content with pharma-backed search results that promote junk food and drugs as “healthcare” solutions
  • A new term, “nonaginate,” describes Google’s tactic of wiping out 90% or more of alternative health websites’ visibility — a practice now threatening hundreds of holistic sources
  • Under the guise of safety, Google uses vague policies like EEAT and YMYL to bury licensed doctors and researchers who question mainstream pharmaceutical narratives
  • Google’s so-called “quality raters” depend on Wikipedia for judgments about credibility — even though its anonymous editors openly oppose natural health and block factual corrections
  • To protect your health freedom and privacy, I recommend ditching all Google products — from search to Gmail — and switching to platforms that respect your data and independence

Have you noticed how it’s getting more challenging to find non-mainstream health info in your search results lately? That’s not your imagination — it’s a deliberate tactic employed by Google to control the information you see. They’re targeting websites that question pharmaceutical orthodoxy or promote natural approaches to health, even those that are run by licensed practitioners, researchers, and authors with longstanding reputations — myself included.

I’ve been sounding the alarm on Google’s monopoly for several years now, and how they’re gravely endangering the free-flow of information, particularly in the health industry. Google views alternative health as a threat to Big Pharma, and uses its search ranking system to severely reduce natural health websites’ visibility and accessibility to the general public.

‘Nonagination’ — Google’s Attempt to Suppress Alternative Health Information

In his Substack page, Bill Dembski, a researcher, design theorist, and mathematician, wrote an extensive exposé on “the evilization of Google,”1 and how this nefarious company strategically dismantled the reach and visibility of alternative health websites, including Mercola.com. Dembski introduced the term “nonaginate” to describe a tactic that goes far beyond censorship.2

What does “nonaginate” mean? Dembski says this word was inspired by “decimate,” which dates to the old Roman practice of eliminating “one-tenth of an unruly band of Roman soldiers.” However, what Google does is so much worse, so using the word decimate is a grave understatement.

It’s much worse than decimation — Dembski then turned to the Latin term for 90, “nonaginta,” and from here, he coined the word “nonaginate,” saying that this was a better-suited word for what this company does.

“Nonaginate — hat tip to Google for inspiring the term — is thus defined as destroying at least ninety percent of a thing. Nonagination is therefore much more extreme than decimation (in decimation’s strict literal sense of only destroying ten percent). Google prefers to nonaginate sites it doesn’t like,” he writes.

I first-handedly experienced nonagination back in 2019 — Six years ago, on June 3, 2019, to be exact, Google implemented a broad “core update” that eliminated most Mercola.com pages from its search results. Virtually overnight, Google traffic to my site dropped by approximately 99.9%.

Decades of valuable health information has been buried — Since 1997, Mercola.com has been considered a highly relevant source of health content, and has been one of the top natural health websites worldwide. But in one fell swoop, Google removed all our high-ranked results, and replaced them with health information from advertising companies that promote junk food and drugs instead.

Google Hides Behind Its So-Called ‘Policies’

Mercola.com wasn’t the only victim of nonagination — countless alternative health websites were also hit with similar penalties, losing their visibility, reach, and revenue streams. For many, this meant bankruptcy. Yet, Google does not publicly admit to this bias; instead, it hides behind abstract policy language.3

Bias is hidden behind policies that claim neutrality — To justify its move to downrank alternative health websites, Google invokes content guidelines like “Experience, Expertise, Authoritativeness, and Trustworthiness” (EEAT), and “Your Money or Your Life” (YMYL).4

On paper, these standards sound like they exist to protect users — But in practice, they create a false sense of objectivity that allows Google to bury dissenting voices without admitting to any ideological filtering. Even licensed physicians and researchers are downgraded if they suggest that healing might come from something other than patented drugs.

This suppression is systemic, not incidental — EEAT and YMYL policies are enforced by both machine algorithms and human raters, all trained to flag anything outside of conventional dogma as untrustworthy — even if that information is backed by clinical experience or published studies.

The result? Websites that promote natural, research-backed concepts like real food, mitochondrial health, sunlight exposure, or EMF reduction are treated the same way as snake oil scams. Google nonaginates them in the name of “safety.”

From Crowdsourcing to Crowd Control

In the past, google search results were based on crowdsource relevance. An article’s rankings on Google search would ascend based on the number of people who clicked on it. Basically, if you produced unique and high-quality content that matched what people were looking for, you were rewarded by ranking in the top of search results.

To help you ideate this, here’s an example — Let’s say you have an article about Akkermansia that is found on the seventh page of Google’s search results, and then your competitor also has an Akkermansia article on the fifth page of search results. If more people click on your article than your competitor’s, your article will move up in rank. So, in a nutshell, these search results are based on popularity.

But this is no longer the case — Now, Google is manually lowering the ranking of undesirable content with the help of “quality raters.” These raters are basing their feedback largely on Wikipedia’s assessment of the author or site (more on this in the next section).

Who are these so-called quality raters? According to the company’s Search Quality Rater Guidelines, they have 16,000 external search quality raters working for them to “provide ratings based on our guidelines and represent real users and their likely information needs, using their best judgment to represent their locale.”5

However, these raters are not Google employees — Rather, they are employed by external firms who have contracted them to Google. According to an article by ARS Technica:

“They’re carefully trained and tested staff who can spend 40 hours per week logged into a system called Raterhub, which is owned and operated by Google. Every day, the raters complete dozens of short but exacting tasks that produce invaluable data about the usefulness of Google’s ever-changing algorithms.

They contribute significantly to several Google and Android projects, from search and voice recognition to photos and personalization features.”6

Google Quality Raters Rely on Wikipedia for ‘Expertise’ and ‘Trustworthiness’

As mentioned earlier, one of the primary sources Google’s quality raters are instructed to use when assessing the expertise, authoritativeness and trustworthiness of an author or website is Wikipedia, “the free encyclopedia.”

Wikipedia is highly biased against natural health — Unfortunately for many of us in the field of alternative health, Wikipedia’s founder and editors are well-known to have extreme bias against natural health content and authors.

What’s more, the editors are completely anonymous — Wikipedia’s editors are purely volunteers, and there are a few who have reached the most powerful editing status. They’re known as the administrators. However, you will not know their identity as they hide behind pseudonyms and usernames.

So, basically, you have no idea whether the editors who are editing your content are truly experts on the topic. So how can we consider Wikipedia to be an authority of credibility when the editors are anonymous and uncredentialed?

Wikipedia Is Aggressive When It Comes to Censorship

While Google’s censoring of content started just several years ago, Wikipedia has been censoring information and blocking editors since the beginning. About 1,000 users are blocked from the platform on any given day.

Wikipedia is often edited by people with a very specific agenda — According to investigative journalist Sheryl Attkisson, anyone who tries to clarify or clear up inaccuracies on the site is simply blocked. The reality is a far cry from Wikipedia’s public promise, which is to provide readers with unbiased information.

Google is funding Wikipedia — Considering its history of bias and its incredibly effective blocking of opposing views, no matter how factual, it’s not surprising that Wikipedia is Google’s chosen arbiter of expertise and credibility. And Wikipedia is profiting from this partnership, financially speaking. In January 2019, Google donated $2 million to Wikimedia Endowment, Wikipedia’s parent organization, and another $1.1 million to the Wikimedia Foundation.

So what does this mean? Since Google’s freelance raters rely on Wikipedia, it means the whole “quality rating” system they’ve set up is rotten from the ground up, as its quality raters are instructed to base their quality decisions on an already biased source.

Google Is the World’s Biggest Monopoly

There’s no doubt that Google is now one of the largest and clearest monopolies in the world. It monopolizes several different markets, including search and advertising. In the case of search, it controls 90% of the market; its closest competitor, Bing, only has 2% of the market.7 Google also controls about 60% of the global advertising revenue on the internet.

Google’s primary business is the harvesting of user data — Google catches every single thing you do online if you’re using a Google-based feature, and this data is then used to build powerful personality profiles that are sold for profit and used in a variety of different ways.

This data gathering goes far beyond what most people realize was even possible and is one of the primary reasons smaller advertisers cannot compete — they don’t have the user data Google has.

Google also owns DeepMind, the world’s greatest artificial intelligence (AI) company — With nearly 6,000 employees worldwide,8 many of them AI researchers, it is not hard for them to sort through all your data with their deep learning algorithms to detect patterns that can be exploited for profit.

Unfortunately, many still fail to see the problem Google presents — Its services are useful and practical, making life easier in many ways, and more fun in others. However, the complete and utter loss of privacy is a high price to be paid for such conveniences. Ultimately, your user data and personal details can be used for everything from creating personalized advertising to AI-equipped robotic warfare applications.

Say Goodbye to Google Today

Today, being a conscious consumer includes making wise, informed decisions about technology, and one of the greatest personal data leaks in your life is Google. If you need an extensive list on just how pervasive Google is, I recommend reading my article, “Goodbye Google.”

Here’s a summary of action steps for you to take right now to protect your privacy. I recommend sharing them with your friends and family so they too can protect themselves from Google’s data theft practices.

Swap out your browser — Uninstall Google Chrome and use Brave or Opera instead. Everything you do on Chrome is surveilled, including keystrokes and every webpage you’ve ever visited. Brave is a great alternative that takes privacy seriously.

Switch your search engine — Stop using Google search engines or any extension of Google, such as Bing or Yahoo, both of which draw search results from Google. Instead, use a default search engine that offers privacy, such as Presearch, Startpage, DuckDuckGo, Qwant and many others.

Use a secure email — Close your Gmail account and switch to a secure email service like ProtonMail. If you have children, don’t transfer their student Google account into a personal account once they’re out of school.

Switch to a secure document sharing service — Ditch Google Docs and use another alternative such as Zoho Office, Etherpad, CryptPad, OnlyOffice or Nuclino, all of which are recommended by NordVPN.9

Delete all Google apps from your phone and purge Google hardware — Better yet, get a de-Googled phone. Several companies now offer them, including Above Phone.

Avoid websites that use Google Analytics — To do that, you’ll need to check the website’s privacy policy and search for “Google.” Websites are required to disclose if they use a third-party surveillance tool. If they use Google Analytics, ask them to switch!

Use a secure messaging system — To keep your private communications private, use a messaging tool that provides end-to-end encryption, such as Signal.

Use a virtual private network (VPN) such as NordVPN or Strong VPN — This is a must if you seek to preserve your online privacy.

Don’t use Google Home devices in your house or apartment — These devices record everything that occurs in your home, both speech and sounds such as brushing your teeth and boiling water, even when they appear to be inactive, and send that information back to Google. The same goes for Google’s home thermostat Nest and Amazon’s Alexa.

Don’t use an Android cellphone, as it’s owned by Google.

Ditch Siri, which draws all its answers from Google.

Don’t use Fitbit — It was recently purchased by Google and will provide them with all your physiological information and activity levels, in addition to everything else that Google already has on you.

https://articles.mercola.com/sites/articles/archive/2025/07/14/google-silencing-alternative-health-websites.aspx?ui=f460707c057231d228aac22d51b97f2a8dcffa7b857ec065e5a5bfbcfab498ac&sd=20211017&cid_source=dnl&cid_medium=email&cid_content=art1HL&cid=20250714_HL2&foDate=true&mid=DM1774998&rid=340020525

And Now, An AI Mind Reader

New ‘Mind-Reading’ AI Predicts What Humans Will Do Next, And It’s Shockingly Accurate

FACT CHECKEDVERIFIED

 

Artificial Intelligence As Human

(Image by metamorworks on Shutterstock)

In a nutshell

  • Scientists created an AI called Centaur that can predict human behavior across any psychological experiment with unprecedented accuracy
  • The AI outperformed decades-old specialized models and successfully predicted behavior in completely new scenarios it had never seen before
  • Centaur’s internal workings became more aligned with human brain activity just by learning to predict our choices, potentially revolutionizing our understanding of cognition

MUNICH — An artificial intelligence system can now predict your next move before you make it. We’re not just talking about whether you’ll click “buy now” on that Amazon cart, but rather how you’ll navigate complex decisions, learn new skills, or explore uncharted territory.

Researchers have developed an AI called Centaur that accurately predicts human behavior across virtually any psychological experiment. It even outperforms the specialized computer models scientists have been using for decades. Trained on data from more than 60,000 people making over 10 million decisions, Centaur captures the underlying patterns of how we think, learn, and make choices.

“The human mind is remarkably general,” the researchers write in their paper, published in Nature. “Not only do we routinely make mundane decisions, such as choosing a breakfast cereal or selecting an outfit, but we also tackle complex challenges, such as figuring out how to cure cancer or explore outer space.”

An AI that truly understands human cognition could revolutionize marketing, education, mental health treatment, and product design. But it also raises uncomfortable questions about privacy and manipulation when our digital footprints reveal more about us than ever before.

How Scientists Built a Digital Mind Reader AI

The research team started with an ambitious goal: create a single AI model that could predict human behavior in any psychological experiment. Their approach was surprisingly straightforward but required massive scale.

Scientists assembled a dataset called Psych-101 containing 160 experiments covering memory tests, learning games, risk-taking scenarios, and moral dilemmas. Each experiment was converted into plain English descriptions that an AI could understand.

Rather than building from scratch, researchers took Meta’s Llama 3.1 language model (the same type powering ChatGPT) and gave it specialized training on human behavior. They used a technique that allows them to modify only a tiny fraction of the AI’s programming while keeping most of it unchanged. The entire training process took only five days on a high-end computer processor.

Image depicting a human brain connected to artificial intelligence
Centaur could mark a new turning point in AI in its unprecedented ability to understand the human mind. (Image by Shutterstock AI Generator)

Centaur Dominates Traditional Cognitive Models

When tested, Centaur completely crushed the competition. In head-to-head comparisons with specialized cognitive models that scientists spent decades perfecting, Centaur won in almost every single experiment.

The real breakthrough came when researchers tested Centaur on completely new scenarios. The AI successfully predicted human behavior even when the experiment’s story changed (turning a space treasure hunt into a magic carpet adventure), when the structure was modified (adding a third option to a two-choice task), and when entirely new domains were introduced (logical reasoning tests that weren’t in its training data).

Centaur could also generate realistic human-like behavior when running simulations. In one test involving exploration strategies, the AI achieved performance comparable to actual human participants and showed the same type of uncertainty-guided decision-making that characterizes how people behave.

Neural Alignment: Centaur Mimics Human Brain Activity

In a surprising discovery, Centaur’s internal workings had become more aligned with human brain activity, even though it was never explicitly trained to match neural data. When researchers compared the AI’s internal states to brain scans of people performing the same tasks, they found stronger correlations than with the original, untrained model.

Learning to predict human behavior apparently forced the AI to develop internal representations that mirror how our brains actually process information. The AI essentially reverse-engineered aspects of human cognition just by studying our choices.

The team also demonstrated how Centaur could accelerate scientific discovery. They used the AI to analyze human behavior patterns, leading to the discovery of a new decision-making strategy that outperformed existing psychological theories.

“We’ve created a tool that allows us to predict human behavior in any situation described in natural language – like a virtual laboratory,” says lead author Marcel Binz in a statement.

What’s Next for Human Behavior AI?

While impressive, this research represents just the beginning. The current version focuses primarily on learning and decision-making, with limited coverage of areas like social psychology or cross-cultural differences. The dataset also skews toward Western, educated populations, a common limitation in psychological research.

The team plans to expand their dataset to include more diverse domains and populations, envisioning a comprehensive model that could serve as a unified theory of human cognition. They’ve made both their dataset and AI model publicly available for other researchers to build upon.

“We combine AI research with psychological theory – and with a clear ethical commitment,” adds Binz. “In a public research environment, we have the freedom to pursue fundamental cognitive questions that are often not the focus in industry.”

For the first time, we have an artificial system that can predict human behavior across the full spectrum of psychological research with unprecedented accuracy. Whether that development excites or concerns you may depend on how confidently we can ensure such tools are used responsibly.

from:    https://studyfinds.org/ai-thinks-like-humans-unprecedented-accuracy/

 

Genomic Mapping, Disease, and COntrol

(This is the introduction from an article in his substack)

‘Predicting future disease with AI’—just as I wrote, here it is—disaster

No surprise it would be taking over in the UK, where the Nanny State boobs are some of the most deranged on the planet.

Buckle up.

BBC: “Every newborn baby in England will have their DNA mapped to assess their risk of hundreds of diseases, under NHS plans for the next 10 years.”

“…part of a government drive towards predicting and preventing illness…”

“The government’s 10-year plan…is aimed at easing pressure on [medical] services. The Department for Health and Social Care said that genomics—the study of genes—and AI would be used to ‘revolutionise prevention’ and provide faster diagnoses and an ‘early warning signal for disease’.”

This is complete bullshit.

The study of genes to treat disease is aimed largely at raising MONEY for research.

Aside from isolated “miracle cases” here and there, there are NO genetic cures for any disease.

So how in the world will analyzing the DNA of every baby add up to “better medical care?”

What WILL happen is lots more government surveillance of citizens from cradle to grave—using their DNA profiles—under the convenient do-good cover story of “we’re catching disease earlier and treating it.”

Also, the people of the UK can look forward to hundreds more nonsense disease labels, supposedly describing what “genetic research” is uncovering.

Every person will be a captive of the medical cartel from birth to death. Featuring all new toxic drugs and vaccines. (link)

from:    https://jonrappoport.substack.com/p/predicting-future-disease-with-ai-here-it-is-disaster?publication_id=806546&post_id=166748126&isFreemail=true&r=19iztd&triedRedirect=true&utm_source=substack&utm_medium=email

And Today’s Movie Is: THE BIBI FILES

Free Movie: The Bibi Files. Israeli Prime Minister Netanyahu Could Go to Prison If He Is Voted Out of Office

The Bibi Files is a film that features leaked interrogation footage from the trial of Israeli Prime Minister Benjamin (Bibi) Netanyahu.

He faces corruption charges that may to lead to a prison sentence if he loses his seat in office. Critics say that he has prolonged the Gaza war in order to keep his post as prime minister and avoid being tried on corruption charges for accepting lavish gifts and bribing the media for positive news coverage.

The corruption charges include accepting expensive gifts that include champagne for his wife Sara, who witnesses in the film say drinks excessively. Hollywood film producer Arnon Milchan said that he bought her a necklace. It is alleged that Milchan, who revealed that he secretly helped Israel develop its nuclear weapons program, received benefits from Netanyahu. Critics believe that Sara Netanyahu sets policy and gained power after Bibi admitted to an affair in 1993.

Miriam Adelson, who pledged $100 million to Trump in the 2024 election made a startling statement when she was asked if the basis of the Adelson’s friendship with the Netanyahus was money. She replied, “What can I say? If this comes out, I am dead.”

.

Excerpts from Al Jazeera December 2024:

Analysts and observers posit that in his [Netanyahu’s] efforts to avoid the trials and possible conviction, Netanyahu has been extending and expanding Israel’s assault on the besieged Gaza Strip.

Interactive_Netanhyahu_prosecution_charges_trial_Israel_court_Dec2_2024-1733138488

  • Save

Here’s a breakdown of what he is accused of doing:

Case 1000

Also known as the “Gifts Affair”, this case charges the Israeli prime minister with fraud and breach of trust.

It involves allegations that Netanyahu and his wife Sara received lavish gifts from two wealthy businessmen in exchange for political favours.

The businessmen are Arnon Milchan, an Israeli Hollywood film producer, and Australian billionaire James Packer. The gifts allegedly include champagne and cigars.

Milchan testified that he provided gifts to Netanyahu in June 2020.

Netanyahu is accused of advancing Milchan’s interests by helping secure a United States visa after speaking to US government officials.

He is also accused of advancing a tax exemption law that could have benefitted Israelis abroad, including Milchan.

Fraud and breach of trust can result in prison sentences of up to three years, while bribery charges can result in up to 10 years in jail and/or a fine.

Then-Attorney General Avichai Mandelblit said the gifts were given continuously, “such that they became a sort of ‘supply channel’”.

The goods were valued at approximately 700,000 shekels ($186,000), according to a statement made by Mandelblit following the indictment, and were given to Netanyahu “in connection with his public roles and his status as Israel’s Prime Minister”.

Case 2000

It says Netanyahu made a deal with businessman Aron Mozes, a controlling shareholder of the Israeli daily Yedioth Ahronoth, for favourable coverage in exchange for legislation to slow the growth of the rival Israel Hayom newspaper.

This case also charges him with fraud and breach of trust.

In Mandelblit’s indictment summary, he said despite “a profound rivalry” between the two men, they conducted three series of meetings between 2008 and 2014.

During these meetings, Netanyahu and Mozes “engaged in discussions regarding the promotion of their common interests: improving the coverage that Mr. Netanyahu received in the ‘Yedioth Aharonoth’ media group; and the imposition of restrictions on the ‘Israel Hayom’ newspaper”, Mandelblit said.

A legislative bill was also being considered that would have limited the circulation of Israel Hayom, according to the indictment’s summary.

Case 4000

This case indicts Netanyahu for granting regulatory favours to Israeli telecommunications company Bezeq in return for positive coverage of him and his wife on a news website controlled by its former chairman.

Netanyahu, in his capacity as communications minister at the time, allegedly provided regulatory benefits to Shaul Elovitch, the owner of Bezeq who also controlled the news website Walla.

The benefits reportedly included mergers and financial gains.

In exchange, Elovitch provided favourable coverage of Netanyahu and his wife.

Netanyahu “dealt on several occasions with regulatory matters pertaining to Mr Elovitch, and took specific actions that promoted significant business interests of Mr Elovitch of substantial financial value”, the indictment summary said.

Besides fraud and breach of trust, Netanyahu has been charged with bribery in this case.

Read full article here…

from:    https://needtoknow.news/2025/06/free-movie-the-bibi-files-israeli-prime-minister-netanyahu-could-go-to-prison-if-he-is-voted-out-of-office/

“We Need More People”?

Soros In Favor of Migrant CHild Trafficking?

Soros-Linked Groups Sue to Stop Trump’s Migrant Child Trafficking Crackdown

Jacumba Hot Springs, CA, Sunday, May 12, 2024 - Families board a Border Patrol vehicle at
Robert Gauthier/Los Angeles Times via Getty Images

Two left-wing non-governmental organizations (NGOs), both with financial ties to Alex and George Soros’s network, are suing to stop President Donald Trump’s reforms of the Unaccompanied Alien Children (UAC) program, which are intended to end trafficking of such migrant children within the United States.

In February, Trump’s Department of Health and Human Services (HHS) issued reforms to the UAC program, which resettles migrant children in American communities with adult sponsors after they arrive at the U.S.-Mexico border without parents or guardians.

Part of those reforms is banning UACs from being turned over to illegal aliens in the United States.

HHS whistleblower Tara Lee Rodas has called the UAC program a “white glove delivery service” where migrant children go from Department of Homeland Security (DHS) custody to HHS custody before being turned over to adult sponsors that are not their parents or relatives, in most cases.

“…we have delivered these unaccompanied children to criminals, traffickers, and members of transnational criminal organizations who are using the UAC program as a white glove delivery service of children,” Rodas said, calling out former President Joe Biden’s administration for loosening the rules around the UAC program.

This week, the National Center for Youth Law and Democracy Forward — both with financial ties to the Soros network — filed a class action lawsuit to stop Trump’s HHS from verifying the legal status of an adult sponsor before a UAC is handed over to their care.

The groups are asking a district court to find the reforms unlawful and issue a preliminary injunction stopping the administration from implementing the reforms.

Democracy Forward, which is behind a separate lawsuit trying to stop Trump from deporting illegal alien gang members, lists left-wing organizations like the Center for American Progress, National Immigration Law Center, Color of Change, UnidosUS, Common Justice, and the Catholic Legal Immigration Network, among many others, as clients and partners.

The Alex Soros-chaired Open Society Foundations has funded several of Democracy Forward’s clients and partners. For example, in 2023, the Open Society Foundations awarded Color of Change a $3 million grant after giving the group nearly $1.5 million in funding in 2018 and 2019.

Similarly, and perhaps most significantly, the Open Society Foundations remains one of the largest donors to the Center for American Progress — a group that is considered the unofficial policy wing of the Democrat Party.

In 2023 alone, the Open Society Foundations gave the Center for American Progress nearly $4 million in grant funding.

Likewise, the Open Society Foundations has thrown millions to the National Immigration Law Center as well as hundreds of thousands of dollars in funding to UnidosUS, Common Justice, and the Catholic Legal Immigration Network.

The other group involved in the lawsuit, the National Center for Youth Law, received $75,000 in funding from the Open Society Foundations in 2017.

The case is Immigrant Defenders Law Center v. HHS, No. 1:25-cv-01405 in the U.S. District Court for the District of Columbia.

John Binder is a reporter for Breitbart News. Email him at jbinder@breitbart.com. Follow him on Twitter here.

from:    https://www.breitbart.com/politics/2025/05/09/soros-linked-groups-sue-to-stop-trump-migrant-child-trafficking-crackdown/

Another Face Of the Surveillance Monster

The most dangerous man in America isn’t Trump—it’s Alex Karp

If Orwell warned us about Big Brother, Palantir CEO Karp is quietly building his AI-powered control room
Don’t let Palantir CEO Alex Karp’s whacky professor look fool you. Image: YouTube Screengrab

Alex Karp doesn’t look like a warmonger. The Palantir CEO is often photographed in quirky glasses and wild hair, quoting St Augustine or Nietzsche as if he were auditioning for a TED Talk on techno-humanism.

But behind the poetic digressions and philosophical posturing is a simple truth: Karp is building the operating system for perpetual war. And he’s winning.

For years, Karp was treated like a curiosity in Silicon Valley—too weird, blunt and tied to the military-industrial complex. “We were the freak show,” he once said, half-proud, half-wounded.

But today, he’s not just inside the tent. He’s drawing the blueprint for a new kind of techno-authoritarianism where AI doesn’t just observe the battlefield—it becomes the battlefield.

Palantir’s flagship product, AIP, is already embedded in US military operations. It helps with target acquisition, battlefield logistics, drone coordination, predictive policing and data fusion on a scale that would make the National Security Agency (NSA) blush.

Karp boasts that it gives “an unfair advantage to the noble warriors of the West.” Strip away the romantic rhetoric, and what he’s offering is algorithmic supremacy—war by machine, guided by code, sold with patriotic branding.

And corporate America is buying. Citi, BP, AIG and even Hertz now use Palantir’s product. The line between military and civilian application is evaporating.

Surveillance tech once designed for combat zones is now monitoring customers, employees and citizens. Karp doesn’t just want to power the Pentagon. He wants Palantir in schools, hospitals, courts and banks.

What makes him so dangerous isn’t just the tech—it’s the belief system. Karp talks about “transforming systems” and “rebuilding institutions” like he’s Moses on a mountaintop.

But beneath the messianic tone is something more chilling: a conviction that democratic drag—messy deliberation, public resistance, moral caution—is something to be bypassed. He’s not selling tools; he’s selling inevitability.

Karp doesn’t hide his politics. He’s pro-military, anti-transparency and openly contemptuous of Silicon Valley’s squeamishness. While other CEOs flirt with ethics boards and open letters, Karp says the quiet part loud: Palantir is here to wage war—on inefficiency, on bureaucracy, on enemies foreign and domestic.

He ridicules the idea that tech should be restrained by liberal hand-wringing or ethical hesitation. To Karp, the moral compass is obsolete. What matters is effectiveness—disruption, domination, and deployment. He speaks like someone who doesn’t just want to assist power, but to optimize it, weaponize it, and automate it.

This isn’t a CEO seeking balance; it’s a man forging the software layer of the surveillance state and calling it liberation. The software doesn’t just solve problems; it decides which problems are worth solving.

Palantir’s rise mirrors a “massive cultural shift,” Karp says. He’s right. America is leaning harder into surveillance, speed and simulated control. His systems offer all three.

And unlike Meta’s Mark Zuckerberg or SpaceX’s Elon Musk—who still pretend to sell social goods—Karp makes no apologies. He’s proud that his software underwrites missile strikes, ICE raids and predictive dragnet surveillance. He calls it progress.

And it is working. Palantir is now one of the most highly valued defense contractors in US history, trading at 200x projected earnings. Wall Street loves him, and Washington loves him more.

He’s already delivered TITAN vehicles to the US Army and spearheaded the AI-powered Maven program that turns satellite data into instant strike intelligence. That’s not just infrastructure; that’s imperial logistics.

The philosopher-warrior routine may impress investors and national security hawks, but the rest of us should be alarmed. Karp is selling a future where wars don’t need public support—just a backend.

He’s selling a future where morality is outsourced to code and every human interaction becomes a data point to be processed, scored and acted upon.

If Orwell warned us about Big Brother, Karp is quietly building his control room. Not with fanfare, not with propaganda—but with procurement contracts and PowerPoint decks. Not in backrooms with shadowy spymasters, but in full daylight with press releases and Q1 earnings calls.

While others sell platforms, Karp sells architecture—digital, total and permanent. His danger lies in the fact that he seems civilized. He quotes scripture, wears Patagonia and looks like a cool professor.

But behind the affectation is a man laying track for a future where dissent is a glitch, ambiguity is a flaw and the human is just another inefficiency to be engineered out.

His vision—total awareness, preemptive decision-making, seamless militarization of every institution—is, in many ways, truly terrifying. So, while the media obsesses over Trump’s theatrics, keep your eyes on Alex Karp.

The most dangerous man in America doesn’t shout, he codes.

from:    https://asiatimes.com/2025/05/the-most-dangerous-man-in-america-isnt-trump-its-alex-karp/#

And Underneath It All…..

Catherine Fitts: Power Grids, Bankers vs. the West, Secret Underground Bases, and Extinction Events

Catherine Austin Fitts said that $21 trillion in taxpayer funds have been funneled into the US space program and underground bunkers. The underground cities were constructed from 1998 to 2015 for elites in anticipation of a doomsday extinction event. She said there were about 170 underground bases across the US and some are located beneath the ocean. She added that a secret military energy systems is likely powering these sites.

Mark Zuckerberg recently admitted on the Theo Von show that he has an underground tunnel on his property in Hawaii, but refused to give details.

Congressman Tim Moore showed the tunnel underneath the Lincoln Library in the Capitol in a recent video (read more here).

.

From The Economic Times:

A former Bush administration official has made startling claims, alleging that the United States government has built an extensive underground network of bunkers worth $21 trillion. The bunkers, as the official said, were constructed from 1998 till 2015 and with ‘unauthorised spending’, according to a report.

Catherine Austin Fitts, the Secretary of Housing and Urban Development from 1989 until 1990, under the former President George HW Bush, made these claims during an interview on Tucker Carlson’s podcast. Fitts stated that the hidden funds were funnelled into construction of around 170 underground bases across the US. She added that some of these bunkers are located beneath the oceans, The Independent reported.

Fitts told Carlson that it was built in anticipation of a doomsday. Moreover, she suggested these bases were designed to shelter the elite and powerful, while also serving as sites for secret government projects, including space programs.

Mystery of Missing Trillions

According to The Independent report, Fitts cited a 2017 report by Michigan State University economist Mark Skidmore which probed into massive unauthorised financial adjustments within the Departments of Defence and Housing & Urban Development.

Skidmore’s report mentioned that $21 trillion in unsupported adjustments was recorded between 1998 and 2015. This raised questions on the whereabouts of these funds.

The 2015 report indicated that the US Army had $6.5 trillion in unsupported adjustments, despite an annual budget of just $122 billion. These adjustments are normally minor, which made the scale of these figures highly unusual.

Underground Cities and Secret Bases

Fitts inferred that at least 170 underground facilities exist on the US soil and near its coastlines, after conducting a two-year probe and reviewing available documents. She suspects there are more facilities worldwide.

The former federal officer described a sophisticated underground transportation network and hinted that a secret military energy system is likely powering these sites. Fitts further suggested that some of the fast-flying unidentified aerial phenomena spotted in recent years could be connected to it.

Read full article here…

Mark Zuckerberg on Theo Von’s podcast:
.

SOme Information on DMSO for Cancer

The Forgotten Cancer Cure Hiding in Plain Sight

How DMSO turns a common dye into a highly potent cancer treatment that’s harmless to normal tissue

Story at a Glance

•DMSO is a safe and naturally occurring substance that is remarkably effective for a wide range of diseases including pain, injuries, and strokes.

•DMSO effectively dissolves a variety of medications and can transport them throughout the body. This increases their potency, makes it possible to administer them through the skin, and allows them to target things deep within the body (e.g., resistant infections) that other therapies have difficulty reaching.

•Through various mechanisms, DMSO selectively targets cancer cells and simultaneously mitigates the consequences of cancer therapies. It also brings conventional and natural cancer therapies to tumors, thereby significantly increasing the potency of these therapies (while simultaneously allowing a much lower and less toxic dose to be used).

•When DMSO is combined with hematoxylin (a dye widely used in pathology), it becomes a highly potent cancer treatment, both harnessing DMSO’s intrinsic anticancer properties and directly destroying cancer cells. It is also highly specific to targeting cancers while not affecting normal cells, thereby allowing it to dissolve cancers at doses that have virtually no toxicity to the patient.

•Despite its ingredients being relatively easy to procure and producing remarkable results, this therapy (like many other alternative cancer treatments) was almost completely forgotten. Fortunately, a narrow thread of knowledge has kept this sixty-year-old discovery alive, most recently through a doctor who spent the last fifteen years refining this lost therapy and successfully treating cancer patients with it.

•This article will discuss everything known about DMSO-hematoxylin, such as its mechanisms, which cancers it responds to (e.g., it’s very effective for leukemias along with their associated anemias and can often treat advanced cancers no other treatment works for), and with how to use it both at home and within a medical setting.

Over the last six months, I’ve worked to bring the public’s attention to dimethyl sulfoxide (DMSO) a forgotten natural therapy which rapidly treats a wide range of conditions and that many studies have shown is very safe (provided it’s used correctly), and, most importantly (thanks to the 1994 DSHEA act which legalized all natural therapies) is now readily available. Since I believe DMSO has an immense amount to offer to the medical community and individual patients, I’ve thus diligently worked to compile the evidence that would best make the case for its rediscovery. As such, throughout this series, I’ve presented over a thousand studies that DMSO effectively treats:

Strokes, paralysis, a wide range of neurological disorders (e.g., Down Syndrome and dementia), and many circulatory disorders (e.g., Raynaud’s, varicose veins, hemorrhoids), which I discussed here.

A wide range of tissue injuries, such as sprains, concussions, burns, surgical incisions, and spinal cord injuries (discussed here).

Chronic pain (e.g., from a bad disc, bursitis, arthritis, or complex regional pain syndrome), which I discussed here.

A wide range of autoimmune, protein, and contractile disorders such as scleroderma, amyloidosis, and interstitial cystitis (discussed here).

A variety of head conditions, such as tinnitus, vision loss, dental problems, and sinusitis (discussed here).

A wide range of internal organ diseases such as pancreatitis, infertility, liver cirrhosis, and endometriosis (discussed here).

A wide range of skin conditions such as burns, varicose veins, acne, hair loss, ulcers, skin cancer, and many autoimmune dermatologic diseases (discussed here).

Many challenging infectious conditions, including chronic bacterial infections, herpes, and shingles (discussed here).

While unbelievable, consider for a moment this 1980 report by 60 Minutes that corroborates much of that:

Fortunately, much in the same way DMSO’s caught on in the 1960s, providing that evidence again has allowed it to make a rapid resurgence (e.g., I’ve now received over 2000 stories from readers who’ve often had remarkable improvements from using it).

Of the myriad of uses for DMSO, the least appreciated one is its applications in cancer due to the politics around “unproven” cancer therapies:

Dr. Stanley Jacob [the pioneer of DMSO] also is acquainted with Tucker’s work. In fact, he telephoned Tucker a few days before the Mike Wallace 60 Minutes show on CBS-TV to check out progress on the cancer treatment. Jacob plays down the DMSO-cancer connection, because he has enough trouble getting the substance recognized for all of its other special uses. He doesn’t want to have to fight off the label of “cancer quackery” as well.

As such, I recently published an article on DMSO’s remarkable properties for treating cancer and cited hundreds of studies showing that:

•DMSO causes a wide range of cancer cells to transform back into normal cells.
•DMSO slows the growth of many cancers.
•DMSO allows the immune system to target and eliminate cancers it previously was unable to remove.
•DMSO treats many challenging complications of cancer such as cancer pain and amyloidosis from multiple myeloma.
•DMSO protects tissue from radiation and chemotherapy injuries.
•DMSO makes many cancer therapies (e.g., radiation or chemotherapy) more potent, thereby ensuring both a higher treatment success rate and far less complications (as less toxic doses are being used).

Remarkably, despite DMSO’s anticancer properties routinely being used in lab experiments (including those seeking to find anticancer agents with those same anticancer properties), the cancer field has a striking blind spot to DMSO’s use, so in the existing literature, it is almost never discussed as a potential therapeutic.

Of these many uses, I believe the two most noteworthy are DMSO’s ability to mitigate the challenging complications of cancer (e.g., cancer pain or protecting healthy tissue from radiation therapy) and its ability to potentiate other anti-cancer agents.

The Forgotten Side of Medicine is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. To see how others have benefitted from this newsletter, click here!

Combination DMSO Therapies

One of the major advantages and risks of DMSO is that it can bring substances through the skin and significantly increase their potency in the body. On one hand, this is quite advantageous as it makes it possible to administer things which would otherwise require injections through the skin and for much lower doses of them to be needed to get results (e.g., as I showed here, antimicrobials mixed with DMSO are often able to treat a wide range of chronic infections which otherwise resist antimicrobial therapy). However, on the flip side, it greatly increases the risk of toxicity, either by accidentally bringing toxic compounds (e.g., pesticides) into the body that were on the skin prior to applying DMSO (or that were touched afterwards), or increasing the potency of a drug taken in combination with it.

Note: it is well known that healthcare workers who routinely administer chemotherapy periodically have accidental exposures to it (e.g., via vapor inhalation), so organizations like the CDC and NIOSH have worker guidelines about it (as these exposures increase the risk for a variety of issues including cancers). Since DMSO will cause chemotherapy drugs it is mixed with to be absorbed through the skin, it is crucial to be extremely cautious when administering it with chemotherapy drugs (particularly when applying it topically).

Since natural therapies are typically much less toxic than conventional pharmaceuticals and easily available (rather than requiring a prescription) over the years, people have tried combining DMSO with many of them and frequently found significant advantages from mixing them together DMSO.

This also holds true in the field of cancer care, and from reviewing all of the ways in which DMSO has been used to treat cancer, I believe the most promising applications (and which had the strongest data supporting their human use) came from DMSO being used in combination with another natural therapy. Unfortunately, the number of substances DMSO can be combined with is almost endless, and as such, the DMSO field has only scratched the surface of what it can be combined with to treat cancer. Many highly potent cancer treatments are likely waiting to be discovered once the right things are combined with DMSO.

Note: somewhat analogously, in the hundreds of studies I identified that examined if DMSO could differentiate a specific tumor type or improve a particular cancer-related gene (or protein), most of them found DMSO did create an improvement. As such, many other aspects of cancer would likely also be seen to improve following DMSO if they were to be tested.

Hematoxylin

Hematoxylin is a powder obtained from the logwood tree (e.g., grinding the heartwood up, boiling it in water to dissolve the hematoxylin present, and evaporating that mixture so only the powder remains). That tree is native to Central America and was originally used by the Mayans to stain cotton and as a medicinal (e.g., to treat diarrhea and dysentery). After its discovery by the Spanish in 1502, a massive market for it quickly developed due to the textile industry’s need to establish a dependable dye. Before long it began to be mixed with a variety of metal salts so it would remain in fabric (and not wash out).

Since many cellular processes are transparent and hence difficult to see without dyes that can stain them, much later (around 1830) hematoxylin began to be used in pathology where it was discovered (once oxidized into hematein and attached to a metal salt) it was remarkably effective for staining many components of cells including DNA. In turn, because of how well it works, almost two hundred years later, it remains one of the primary stains used in pathology to evaluate tissue (it’s the “H” in H & E stains).

Note: like hematoxylin, DMSO is also obtained from trees. Because each of these compounds is so widely used, they are also very affordable.

Tucker’s Discovery

Currently, most of the drugs we use are developed by a mechanistic system where biologically relevant targets in the body (e.g., receptors or enzymes) are identified through research, then compounds are mass screened through for their ability to affect those targets, with the ones that can elicit some type of pertinent change then run through a funnel (which can involve animal and then sometimes human testing) to identify which from that large pool of candidates elicits a benefit.
Note: compounds are sometimes custom-designed to affect receptors or identified through AI systems rather than physically testing a broad swathe of them.

In contrast, previously, drug design was much more of a hit or miss process, and frequently incredible discoveries would happen either by luck or under a completely mistaken assumption.

For example, the first antibiotic was developed by mixing a substance known to be toxic to bacteria (arsenic) with a dye that stained bacterial cell walls under the theory that the dye would allow arsenic to selectively target bacteria rather than the body (with almost all the attempts failing). After decades of attempts were made to replicate this approach, another dye that functioned as an effective antibiotic was found, but before long it was discovered that the antimicrobial agent was not the dye itself but rather a colorless metabolic product of it, sulfanilamide.

Similarly, one of the most remarkable therapies I know of (Ultraviolet Blood Irradiation) was originally developed under the belief that exposing the entire circulation to UV light would sterilize the bloodstream and hence treat a lethal infection. This did not work (it killed the test dogs) but before long, the inventor accidentally only irradiated a small fraction of the dog’s blood and got a remarkable results as inputting a small amount of UV light into the circulation transforms human physiology and allows the self-healing capacity of the body to treat a wide range of illnesses (e.g. UVBI is a highly effective treatment for bacterial and viral infections, circulatory disorders and autoimmune diseases).

Hematoxylin likewise follows a similar journey. Eli Jordon Tucker, Jr., M.D. was a highly respected orthopedic surgeon in Texas (with many awards and honorary status in a numerous medical societies) who had a wealth of surgical experience and had discovered a variety of pioneering orthopedic techniques from bone research he conducted as a hobby (e.g., he gained renown for discovering how to graft bones from one species to another). Tucker’s bone research required him to purchase cattle from a meat packing company, and in the process, he noticed many of the cows butchers (and meat inspectors) were accepting for slaughter had large cancers covering their faces.

Observing those cancers made Tucker wonder if there was some type of cancer-resisting antibody in those cows, so he began administering extracts of their blood into lab rats and mice with cancers and observed anticancer activity for certain cancers. Since it was unclear how much of a change was occurring, Tucker looked for a dye that could stain the tumors, and eventually realized hematoxylin was the perfect dye because it stained the cancers one color and normal cells another color. Unfortunately, hematoxylin had poor solubility and could not dissolve in normal laboratory solvents or enter solutions, so his ability to use it in his experiments was limited.

So, once DMSO (a potent solvent), came into use around 1963, Tucker tried using it and quickly discovered DMSO not only dissolved hematoxylin but could dissolve a very high concentration of it (e.g., 25g of hematoxylin could be dissolved in 62mL of DMSO). Furthermore, this mixture was excellent for staining cancers and making them visible (e.g., they stood out under the microscope and in gross dissection) as it concentrated in the cancers, but DMSO simultaneously did not stain any other tissues in rats. Most importantly there was a “marked increase in central necrosis of the neoplasm” indicating this mixture could potentially eliminate cancers while sparing normal cells.

Note: hematoxylin (dissolved in carboxymethylcellulose), like many other compounds, had previously been screened for its anticancer activity and in the absence of DMSO, had none, which I suspect was in part due to hematoxylin rather than hematein (which hematoxylin rapidly turns into within the body) being used.

Tucker then decided to conduct toxicity studies (initially in dogs) where he found high concentrations of IV DMSO mixed with hematoxylin had no toxicity to any of the tissues or organs he examined (and did not accumulate in any non-cancerous tissue). Curiously the mixture he made was far less toxic than IV DMSO alone (which is extremely safe and only had toxicity issues at fairly high concentrations), with roughly four times as much IV DMSO being possible for animals to tolerate once it was mixed with hematoxylin.
Note: the only physiologic change he observed from D-hematoxylin was that blood urea nitrogen would typically drop by around 50%, indicating this mixture improved kidney function.

He then began treating spontaneous cancers in animals (e.g., in horses, dogs and cows), which included terminal cases with massive tumors (e.g., a large-cell lymphosarcoma, a small-cell lymphosarcoma, generalized malignant melanoma, a squamous cell carcinoma) along with an osteogenic sarcoma. In all of these cases, there was a prompt response, and the animal subsequently recovered.

Note: Tucker found that hematoxylin alone had no effect on cancer cells (as did previous researchers who tested iton a carcinoma, sarcoma and leukemia cell lines) while subsequent investigators found DMSO alone had a minimal anticancer effects compared to the mixture, whereas they could not administer hematoxylin alone (as without DMSO it is essentially not soluble in an IV solution). Going forward (for brevity) I will refer to the DMSO hematoxylin mixture as “D-hematoxylin” (which is a term I made up while writing this).

William Daniel, former Governor of Guam, one of Tucker’s friends, phoned and told the doctor: “E.J., I have a cancerous dog on my ranch who is suffering terribly. Could you do anything to help him, or should I have him put to death?”

“I’d love to try,” answered Tucker. “I’ll send my technician to pick up the dog right away.”

The technician brought the animal to Tucker’s veterinarian, Dr. Collins, for examination. The vet diagnosed that large-cell lymphosarcoma was permeating the dog’s body. “The poor animal is choking to death from the tumors in his throat, and he has large tumors all over his body,” said Dr. Collins over the telephone. “I don’t think he’ll live long enough to be transported to your laboratory.”

Tucker said, “Transfuse him, give him some blood fast, and let me have him for treatment.”

The physician took the dog, which was barely alive, into the laboratory and injected DMSO-hematoxylon solution intravenously. His technician took over the work and gave the injections daily. Within two weeks, all the tumors had disappeared. It seemed like a miracle to the technician.

Upon Tucker’s examination of the dog, he found that all the large-cell lymphosarcoma tumors had completely regressed. The huge masses in the neck and over the whole body of the animal had gone away, and the dog came out of the treatment completely cured.

The dog was thriving at the laboratory when an unlucky accident caused his death. He ate a large quantity of some meat contaminated with Malathion, an insecticide poison. Tucker performed an autopsy, which revealed no active cancer cells in the vestigial remains of the previously large lymphomatous nodules. Many ghost cells—cells that were formerly cancer but weren’t any kind of cells anymore —appeared in the microscopic sections. Not a single distinguishable cancer cell remained in the dog.

Additionally, in 2019, long after Tucker conducted his toxicity experiments, to help the Ecuador team, Roger Tapia, a veterinary student conducted his own LD50 study as a graduation thesis by giving intraperitoneal injections of D-hematoxylin to 70 mice and determined that:

•The D-hematoxylin LD50 was 1257.16 mg/kg of hematoxylin (± 159.10 mg/kg), which is very safe (and between 10 to 100 times less toxic than many commonly used cancer drugs).
Note: the LD50 of hematoxylin alone is also fairly low (e.g., the oral LD50 is over 2000mg/kg), but relatively little data exits on its actual LD50 as it is not intended for human consumption (e.g., data only exists for the oral LD50 and the actual LD50 is unknown as a high enough dose to be lethal to half of those exposed was never tested).

•At lower doses (e.g., 5.5mg/kg to 550mg/kg) low activity, tremors and accelerated breathing were observed that regressed after an hour, while at higher doses, spasms, suffocation and eventually death occurred (likely due to respiratory collapse).
Note: the authors of the study suspected these symptoms were likely due to the shock of an intraperitoneal injection and it being injected too quickly (all of which can be avoided with a careful IV administration).

•In rats that died, the presence of fluid accumulation was observed in the abdominal cavity and surrounding the lungs which was attributed to vasodilation and increased vascular fragility.

•At all doses (including lethal ones), the mixture did not produce any changes in the shape, weight, or size of the internal organs (which I assumed was due to the fact D-hematoxylin does not accumulate in normal tissues).

The full study can be read here:

DMSO Hematoxylin LD50 study
2.46MB ∙ PDF file

Download

Note: while Tucker found IV DMSO with hematoxylin was a fourth as toxic as DMSO alone, when I compared the IP (intraperitoneal) LD50 value this study obtained to the recognized LD50 values for DMSO, I found DMSO alone was less toxic.

Tucker’s Patients

From these experiments, Tucker gradually determined a workable dosing for D-hematoxylin and hence was prepared to administer it to humans. He began telling his hospital associates of his findings, and before long was approached by a colleague who had a comatose female patient on the verge of dying from inoperable fibrosarcoma. As she was his first human patient, Tucker gave her a very slow infusion, and over weeks of treatment, the tumor gradually receded until it was small enough to remove (at which point she had a full recovery).

Note: in our modern medical bureaucracy a treatment like this most likely could have never gotten approval.

Following this, he treated numerous patients, and due to the FDA banning DMSO research in 1965, conducted a small trial in Panama with a colleague. After much difficulty, in 1968, he got his cases published. There he reported on 37 patients he’d treated with recurrent cancers (excluding those who were terminal or those with markedly elevated BUN). Of them, 70.5% of those who were also on another treatment (radiation, surgery or chemotherapy such as 5-fluorouracil (5FU), methotrexate, and thiotepa) improved, 38.1% who received hematoxylin improved (typically only their symptoms but there was one case of a leiomyosarcoma regressing and being surgically removed) while only 5.4% of those receiving conventional therapy improved.

Younger patients with aggressive cancers generally responded better than older ones, as did those with minimal or no prior chemotherapy and those receiving higher total doses (e.g., 50 infusions) or combined topical and IV D-hematoxylin.

Note: over the decades Tucker was reported to have given his mixture intravenously, orally, intralesionally, intra-arterially, rectally, and topically (with topical applications of D-hematoxylin being particularly helpful for cervical cancer). Conversely, subsequent doctors I’ve spoken to (who found those routes of administration worked) made the obvious conclusion to try injecting D-hematoxylin into tumors, but oddly (in their limited attempts) never found that route worked.

In contrast, patients with more terminal conditions had worse outcomes (something which has held true with virtually every alternative cancer therapy—which is unfortunate since they only get approved for use in terminal cases after everything else failed). Additionally, patients with large-cell lymphosarcoma, giant-cell bone tumors, leiomyosarcoma, and adenocarcinomas of the breast or ovary showed positive responses to D-hematoxylin, while those with squamous-cell carcinomas (cervix, lung, or mouth) and adenocarcinomas (prostate, stomach) exhibited minor positive responses but ultimately succumbed to their cancer.
Note: another author reported D-hematoxylin was effective against squamous cell carcinoma, adenocarcinoma, lymphosarcoma, lymphoma, and such associated malignancies such as Hodgkin’s disease.

Many of these cases were quite noteworthy. Both large-cell lymphosarcoma cases showed complete regression with no recurrence well beyond Tucker’s June 1968 report (one patient died from a heart attack ten years later, while the other remained alive decades later). Additionally, one case of malignant giant-cell tumor, affecting about one-third of the femur, experienced complete regression alongside new bone regeneration.

•Finally, in those 37 cases, complications were minimal (including in one patient who was continually assessed over the course of 72 [2mL] of D-hematoxylin treatments). The most common side-effect in Tucker’s patients were fevers in patients with large tumors (which typically lasted around 35 minutes and were less severe if smaller doses were used or the tumor had begun to shrink). Additionally, if D-hematoxylin was infused too quickly, a few patients developed shortness of breath (which immediately resolved if the infusion was stopped and Demerol was administered). Rashes could also sometimes occur (which were suspected to be due to the absorption of necrotic tumor material). The most severe complications occurred from absorbing large amounts of necrotic tissue matter (e.g., terminal patients with high uric acid levels would stop urinating once too much tumor necrosis occurred) so Tucker was much more cautious with these cases and used smaller doses so he did not eliminate the tumor too quickly. Finally, no changes were observed in the eyes (which was a longstanding unfounded concern about DMSO) or blood cell counts (which is a common issue with chemotherapy).

Note: since this paper (which includes many detailed patient cases) is quite hard to find online, I am including a copy of it.

Tucker Hematoxylin Article
2.39MB ∙ PDF file

Download

 

Sadly, after Tucker published that article, the American Cancer Society (in 1971) published a bulletin it sent to all 58 of its divisions stating D-hematoxylin was an “unproven” remedy which provided very little of substance to refute its efficacy and simultaneously made no mention of any potential toxicity (suggesting D-hematoxylin is quite safe as any signs toxicity would have been used to discredit the therapy). Tucker sadly received so much pushback from his colleagues for using an “unapproved drug” (e.g., despite having earned great respect in the medical community, he was expelled from the staffs of two hospitals for administering the treatment and had a real fear of losing his medical license) so he never published anything further. Similarly, he became much more selective in who he would treat (e.g., only pre-terminal patients and those in a destitute state), and typically did so either for free or a very minimal fee (but nonetheless successfully treated many cancer patients in the years that followed).

Note: Andrew Ivy (who was arguably the most influential doctor in America at the end of World War 2), like Tucker theorized there must be a factor in the blood which resisted cancer, and eventually came across a isolate (from cows injected with a cancer causing fungus who’d then recovered) which did just that. After refusing to sell out to the AMA (who frequently tried to buy out competing therapies), he was blacklisted by both the FDA and AMA, and despite having thousands of compelling and well documented cases showing it worked, effectively had his entire reputation destroyed because he’d promoted an “unproven cancer cure.”

Some of Tucker’s other patients included:

•A 3-year-old boy with diabetes insipidus (which requires routine vasopressin injections) who in 1972 had a terminal case of metastatic endothelioma and Letterer-Siwe disease, where solid palpable cancerous lesions had spread throughout the boy’s head and body, which his doctors had given up on and expected him to die within a few years. Even worse, the father abandoned them to escape confronting the cancer, leaving the mother destitute and struggling to survive. Tucker then gave the boy’s desperate mother a dropper bottle of D-hematoxylin to take 5 drops in distilled water every morning on an empty stomach and instructed her to let her doctors know what she was doing.

Mrs. Lindsey returned the next day totally distraught. Between heavy sobs and tears, she explained how the Texas Children’s Hospital staff became enraged and told her never to come back if she used Tucker’s medicine for her son’s cancer. This meant that her supply of Pitressin for treating the little boy’s water diabetes was completely cut off, since she had no money with which to buy more.

This scene took place within earshot of other patients sitting in Tucker’s reception room. They passed the hat and in a couple of minutes raised $75 for the mother to buy her child’s diabetic medicine.

Fortunately, Tucker’s treatment worked, the boy fully recovered (much to the shock of his ENT doctor who’d diagnosed him as terminal) and when last checked on in 1992 was a large, strong, and healthy 29 year-old boy.

•A woman who’d a seen a three hour 1972 news program by anchorman Ron Stone of KHOU-TV Houston about Tucker’s treatments who sought him out as she had a disseminated large-cell lymphosarcoma (e.g., sizable tumors in her lungs, the common iliac arteries, and the lymph nodes around her aorta) with an expected six month survival (which she had been on high doses of radiation and chemotherapy to no avail for and eventually had to stop the chemotherapy due to a very low white blood cell count). Tucker started her on five D-hematoxylin infusions a week, she stopped experiencing negative side effects from radiation, and a year later was completely cured (and remained so after 28 years of follow-up).

Note: if anyone in Houston can get a copy of that news program from the station (which I know happened as it was mentioned by multiple DMSO authors who provided different details about it), it would be greatly appreciated.

A 41-year old man with a disseminated lymphosarcoma which had failed treatment with maximum radiation and chemotherapy who was expected to only survive for three more months. He received IV D-hematoxylin every other day for three months, after which the tumor completely disappeared, the man stopped further treatment, and had no recurrence up to his death eight years later (from a heart attack).

•A 44-year old man with advanced lymphosarcoma (including a massive lump on his neck) who had been treated for five years with maximum doses of radiation and chemotherapy (which amongst other things left him with an almost complete absence of white blood cells). Daily IV D-hematoxylin shrank his neck tumor from 22.5 inches to 18.75 inches (which was enough for his neck to return to a normal appearance), but he subsequently succumbed to the cancer as he had metastasis throughout his internal organs.

•A 36-year-old man with terminal grade 4 Hodgkin’s disease (e.g., large cancerous nodules on his neck and face, severe swelling in his abdomen and legs, and congestive heart failure) was admitted to the hospital with a prognosis of only days to live. He received D-hematoxylin intravenously and topically over his lungs and after four days, he was well enough to return home. Without continued treatment, his breathing difficulties returned, so he returned to the hospital and had a rapid response to D-hematoxylin (e.g., initial X-rays showed on May 22 showed near-total lung obstruction, but by May 25 a slight clearing appeared, and by July 18 the cancer had disappeared entirely). Following treatment, he remained cancer free until he later died from heart failure.

A 75-year-old man who, in 1984, had a recurrent squamous cell carcinoma on the nose (where one had previously been removed 3 year prior) applied topical D-hematoxylin and within a few weeks, the cancer disappeared and the nose was saved from a disfiguring surgery.

Later, in March 1978, Tucker was invited by a group of New York City doctors to share his treatment. En route, K.C. Pani, M.D. of the FDA, requested that Tucker share his data with Dr. Pani (Tucker had numerous records of cures, X-ray films, and slides to show).

On this trip, Tucker brought Joe Floyd, an Exxon Oil Corporate Executive, who four years earlier had had an advanced metastatic colon cancer (e.g., in the lymph nodes and liver) with a poor prognosis (particularly since it was a rare lymphosarcoma). Following surgery, he was implored to start chemotherapy (by a surgeon whose wife had the same condition) but instead sought out Tucker (as he’d seen the 1972 news program two years earlier). Tucker eventually agreed to treat him on an experimental basis (with both IV D-hematoxylin and daily oral D-hematoxylin). While Floyd’s surgeon’s wife died six weeks later, Floyd “ had no nausea or any of the symptoms usually accompanying chemotherapy” and after 18 months, his CEA levels (a marker for colon cancer) were far below normal, and in the years that followed never rebounded (and likewise over 15 years of followup did not either).

Doctor and patient flew to Rockville, where Tucker presented his case histories to the FDA.

When they came to Floyd’s record, Dr. Pani asked, “How long did this one last, three months?”

Tucker replied, “He is sitting down in the lobby.”

Pani said, “I want to see this dead man.”

They sought out Mr. Floyd, and he told his story. Then the FDA official, visibly impressed, said he would be in touch with Tucker soon. He also mentioned that he was in contact with Dr. Stanley Jacob of Oregon and that he was monitoring the use of DMSO. About one week later the drug was approved for the treatment of interstitial cystitis. Nothing further was done to follow up its use in cancer, except that Tucker received a request from the FDA for “more research.

Note: the FDA had briefly given Tucker permission to study D-hematoxylin in 1970 but withdrew that permission later that year.

Floyd also attempted to reach many other outlets. A letter he wrote to a newspaper, for example, was published in a record of a 1980 hearing Congress held to pressure the FDA to legalize DMSO, part of which said:

While I had been taking treatments from Dr. Tucker I met many of his patients who came by for check ups that he had cured. You can imagine how excited I became over this treatment. I wanted to do something so everybody with cancer could get this drug. I preached it to my friends and acquaintances but alas when one would mention it to their personal physicians, they wouldn’t touch it, especially if it wasn’t approved for general use, the hospitals would not let them use it even if they wanted to. I started writing to Congressmen, would get a Thank You letter with a Rubber Stamp signature. Even when Hubert Humphrey was dying I wrote him a letter, but back came another Thank You with Hubert’s rubber stamp signature.

Next I wrote Jimmy Carter, thinking someone in the White House might see the political possibilities and pass it on to him. But no, it was side tracked over to the FDA. Excitement, the answer did have a real signature, “Harold Davis” Bureau of Drugs (HFD—35). It was the nice “Thank You for concern but we have to protect the people from quackery etc.” He even sent me a brochure by Dr’s Tucker and A. Carrizo [the other author of Tucker’s 1968 paper], the same as I am enclosing for you that Dr. Tucker gave me.

Note: in this letter, Floyd also shared that he saw many “people that started the treatment too late but died without pain, thanks to the DMSO,” an observation also made by modern doctors using D-hematoxylin, and which was demonstrated in three recent studies where IV DMSO was combined with sodium bicarbonate.

Lastly, a few other American doctors besides Tucker also used his treatment (including a few that I know did so recently). However, the only documented case I know of where someone besides Tucker used D-hematoxylin was of a 55-year-old Texas Baptist minister who in 1982 had a tennis ball-sized mass under his ribs which was diagnosed as malignant lymphoma and began receiving large numbers of daily blood draws alongside initiating chemotherapy (chlorambucil). He quickly developed multiple significant symptoms (including the previously painless mass becoming painful), at which point a health food store referred him to a natural cancer clinic (Jasper County Medical Center) where he worked with clinical nutritionist Dr. John Meyer who placed him a mix of natural therapies alongside the clinic giving him both oral and IV D-hematoxylin and proceeded to make a full recovery (during which he quickly noticed chlorambucil made him violently ill and permanently stopped taking it).

Hematoxylin Persists

When DMSO was first discovered, due to its significant positive results, it was the most requested drug in America, and many pharmaceutical companies made substantial investments in researching to bring it to market and recruited roughly 1,500 clinicians to conduct their research. In early 1965, Merck contacted the American Podiatry Association to request their top podiatrists (foot doctors) for their trials. Morton Walker DPM was selected as he’d recently won numerous awards for his scholarship and previous clinical investigations.

He began his research in the spring of 1965 and rapidly saw great benefit in the patients he treated, but unfortunately, that fall, the FDA decided to force the pharmaceutical companies to end all research into DMSO (which, as best as I can gather, was initially due to the fact that the agency did not want to deal with a large number of applications for the myriad of conditions DMSO treated).

This podiatric study of DMSO came to an abrupt halt November 10, 1965, when a “Dear Doctor” letter arrived advising that all research on the project must cease. The FDA demanded that the used and unused supplies of DMSO and all records of patients for whom it was administered must immediately be returned to the sponsoring pharmaceutical company.

I didn’t have to mail these items because a company representative promptly arrived to take everything away—all patient reports, supplies of DMSO, even duplicates of the records. Instructions were given to report any deleterious effects from the product’s use, but there were none. No published report ever appeared in the medical literature on this four-month podiatric study of DMSO’s adaptation for a variety of foot problems. All the records of clinical trial were confiscated, and what follows are strictly the impressions of this researcher twenty-seven years later. They are based on the patients’ personal foot health histories with relation to their individual toe, foot, ankle, or leg problems.

Following this, Dr. Morton Walker became a holistic journalist, and arguably was one of the most prolific people in the genre, compiling dozens of books on the natural therapies being used around the country (many of which I read decades ago). Amongst other things, Walker felt it was critical for Tucker’s work to be preserved, and as such, much of this article was sourced from his 1983 book on DMSO (which was written jointly with William Campbell Douglass MD—a pioneer in the alternative medical field), its 1993 revision, and his 1985 booklet on Holistic Cancer care which was written with John L. Sessions, D.O. (along with a book by journalist Pat McGrady).

On an ironic note, Dr. Tucker himself came down with a form of cancer that would have responded to his DMSO-hematoxylon treatment, but before he could administer it to himself, he fell into a coma. No one had access to his formula except the author of this book, and I did not know Dr. Tucker’s attendants needed it to save his life. Dr. Tucker died [on February 7 1983] only a few months before this book was first published. Its updating and republication may save lives—I hope so!

As such, Walker was able to preserve Tucker’s formula and make a thread of it available to the next generation who chose to search for it.

Jim McCann

There were a few eclectic individuals (some of whom I studied under) who were inventors with science backgrounds who dedicated themselves to collecting many alternative technologies, some of which were medical in nature. One of these men was Jim McCann, a cantankerous Canadian engineer and Jehovah’s Witness born in 1932 who’d created a variety of inventions throughout his life (e.g., a more efficient automobile engine).

On the medical end, at 23, McCann also started researching cancer cures, and about a decade later, adopted DMSO as it hit America. After he learned about D-hematoxylin through Tucker’s 1968 paper, he tried to get ahold of hematoxylin but initially was unable to as access was restricted at that time (and instead focused on EDTA chelation therapy). Eventually, around 1985 he did, at which point he used it on a prostate cancer patient who was on the verge of death, where unsure of what to do, he used a high dose that resulted in a full recovery.

Following this, he treated a few other people in Canada (approximately five), received significant pushback from the alternative medical community for practicing medicine without a license, and in 1995, moved to Riobamba, a town high in the mountains of Ecuador.

Initially, he used DMSO (and chelation therapies like EDTA) to treat stroke and heart conditions, but eventually began also using D-hematoxylin. Since he got results, doctors began seeking him out, and ultimately directly trained approximately 20 doctors (some of whom were not from Ecuador such as a Polish doctor and a doctor from the Philippines who attracted significant attention for successfully treating many COVID patients with ivermectin) along with many patients from around the world (and many Jehovah’s Witnesses from McCann’s community). As a result, Ecuador became a hotbed for alternative therapies, and in McCann’s estimate, roughly 100 doctors there (many of whom he’d never directly trained) began using D-Hematoxylin.

Near the end of his life (at the age of 90) McCann agreed to conduct a lucid interview with one doctor who took ten hour bus rides to see him (which a few parts of can be listened to below).

0:00
-4:39
0:00
-7:53

In it McCann shared:

•Many of the D-hematoxylin doses he used (especially the initial ones) were on the high end because he felt the patient would die soon regardless, so it was worth gambling on a potentially toxic dose to cure them.

•McCann believed a key part of the treatment was D-hematoxylin inducing a 103 degree fever in the body, and that it was critical not to use a fever-suppressing medicine to treat that fever or be in air conditioned rooms. However, in cases where patients did experience a significant reaction, he would administer Benadryl.
Note: This mirrors a viewpoint within the integrative cancer field that fevers are often critical for eliminating fevers (to the point that some groups cure cancer by inducing high fevers) and the anthroposophic perspective that suppressing febrile childhood illnesses with vaccination increases the risk of cancer later in life (which has been shown in quite a few studies regarding measles, mumps, and chickenpox).

•McCann felt strongly that an IV infusion of DMSO should never be combined with prednisone or a blood thinner like warfarin and heparin as this could make them far too potent (e.g., he saw this cause numerous severe adverse reactions after doctors administered mixed infusions against his advice).
Note: the reactions McCann described I have never heard of occurring in patients who were taking DMSO and one of those medications concurrently (e.g., a few DMSO studies I reviewed used topical DMSO combined with heparin found it was a helpful and side-effect free intervention) and I suspect the results McCann saw were from those drugs directly being mixed together with hematoxylin in an IV.

•He felt very strongly about the necessity of chelation therapy in cancer (e.g., to prevent subsequent heart attacks following successful D-hematoxylin treatments—which occurred years later in some of Tucker’s cases) and to that you should not give leukemia patients with anemia iron as the cancer needed that to grow (to the point he would sometimes also chelate iron in leukemic patients).

•McCann was also very focused on cultivating bacteria on a target media that would dissolve specific biological targets (e.g., he cultured bacteria from a dead cow’s cataract and then found it could eliminate other cataracts; likewise, he found this approach worked for cancer).

Note: my experience with individuals like McCann is that some of their insights are spot on while others they have a deep conviction in are ultimately not correct.

The Next Phase

Like many alternative therapies, D-hematoxylin grew up in “the Wild West” of alternative medicine. This was made possible by its very low toxicity profile, which allowed it to be used in humans at widely varying doses without significant side effects.

Fortunately, the threads keeping D-hematoxylin from being lost eventually converged in Ecuador with a doctor who’d successfully treated 44 out of 45 cases of microbiologically confirmed chronic bacterial prostatitis using DMSO combined with antibiotics that were applied directly into the bladder (much in the same DMSO is FDA approved to treat interstitial cystitis) who then tested negative for any infection 15-20 days following treatment (with no subsequent recurrences), demonstrating DMSO’s ability to counteract bacterial resistance.

Note: interestingly, Stanley Jacob, was still alive when these treatments were initiated (he died in 2019 at age 91). At the start of the prostatitis treatments, the doctor in Ecuador contacted him for advice, and Jacob encouraged the experiment, agreeing it was a good idea, even though he hadn’t heard of anyone attempting it before.

As he’d heard of McCann through Ecuador’s medical community, these prostatitis successes inspired that doctor to try intravesical DMSO mixed with hematoxylin for a prostate cancer patient (which was administered in the same manner and frequency as his prostatitis treatments). This worked, and he gradually began using it for other prostate cancer patients and then other cancers as well, which gradually grew into a fifteen-year research project on the therapy (which he’s shared with me over the course of a few months).

Note: I also know of one individual who used D-hematoxylin intrarectally over a prolonged period to locally treat a cancer there, but the data on this approach is still limited.

Recent D-Hematoxylin Patients

That project involved treating approximately 85 patients, with the cure rate in patients who had not previously received chemotherapy averaging between 80-90%. As such D-hematoxylin is an excellent cancer treatment but it is not perfect and will not work for everyone.

To read the rest, go to:    https://www.midwesterndoctor.com/p/the-forgotten-cancer-cure-hiding

(PS:  This guy is amazing!!!)

Actually, It is NOT Yours!

Bank Lobby Threatens ‘Great Taking’ Author David Webb

BY ITM TRADING
MONDAY, MAR 17, 2025 – 14:29

David Webb, author of The Great Taking, just exposed how banks and their political allies have systematically removed your property rights over securities. You might think you own your investments, but legally, your broker does and if they collapse, you have no right to reclaim them.

Webb and G. Edward Griffin have been fighting to strike exemptions in Article 8 of the Uniform Commercial Code, which prioritizes secured creditors over individual investors. But every attempt has been crushed by the banking lobby, which floods state legislatures with money, influence, and outright lies.

State lawmakers are folding under pressure. Banks have rigged the system, and most Americans aren’t lifting a finger to stop it.

The message is clear: no one is coming to save you. If you don’t take action, the banks will own everything—including what you think is yours.

from:    https://www.zerohedge.com/news/2025-03-17/bank-lobby-threatens-great-taking-author-david-webb